What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK city
Open Access
- 31 December 2015
- Vol. 6 (12), e012576
- https://doi.org/10.1136/bmjopen-2016-012576
Abstract
Objective: For patients with advanced cancer, several randomised controlled trials have shown that access to palliative care at least 6 months before death can improve symptoms, reduce unplanned hospital admissions, minimise aggressive cancer treatments and enable patients to make choices about their end-of-life care, including exercising the choice to die at home. This study determines in a UK population the duration of palliative care before death and explores influencing factors. Design: This retrospective cohort study analysed referrals to three specialist palliative care services; a hospital-based inpatient palliative care team, and two community-based services (hospices). For each patient referred to any of the above services we identified the date of first referral to that team and calculated the median interval between first referral and death. We also calculated how referral time varied by age, sex, diagnosis and type of palliative care service. Participants: 4650 patients referred to specialist palliative care services in Leeds UK between April 2012 and March 2014. Results: Median age of the sample was 75 years. 3903 (84.0%) patients had a diagnosis of cancer. Age, diagnosis and place of referral were significant predictors of duration of palliative care before death. Age was independently associated (J=2 672 078, z=-392046.14, r=0.01) with duration of palliative care regardless of diagnosis. Patients over 75 years have 29 fewer days of palliative care than patients under 50. Patients with non-cancer diagnoses have 13 fewer days of palliative care than patients with cancer. Additionally, patients referred to hospital palliative care receive 24.5 fewer days palliative care than those referred to community palliative care services. Conclusions: The current timing of referral to palliative care may limit the benefits to patients in terms of improvements in end-of-life care, particularly for older patients and patients with conditions other than cancer.Funding Information
- National Institute for Health Research (RP-PG-0610-10114)
This publication has 20 references indexed in Scilit:
- Pattern and characteristics of advanced cancer patients admitted to hospices in ItalySupportive Care in Cancer, 2012
- Late Referral to Palliative Care Services in KoreaJournal of Pain and Symptom Management, 2011
- Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2010
- The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: Baseline findings, methodological challenges, and solutionsPalliative & Supportive Care, 2009
- Interval between First Palliative Care Consult and Death in Patients Diagnosed with Advanced Cancer at a Comprehensive Cancer CenterJournal of Palliative Medicine, 2008
- Increased Satisfaction with Care and Lower Costs: Results of a Randomized Trial of In‐Home Palliative CareJournal of the American Geriatrics Society, 2007
- The influence of patient and carer age in access to palliative care servicesAge and Ageing, 2006
- Interval between Palliative Care Referral and Death among Patients Treated at a Comprehensive Cancer CenterJournal of Palliative Medicine, 2005
- Terminal Cancer Patients and Timing of Referral to Palliative Care A Multicenter Prospective Cohort StudyJournal of Pain and Symptom Management, 1999
- The impact on community palliative care services of a hospital palliative care teamPalliative Medicine, 1994